You have accessRestricted access
62 REDUCTION OF ZDV-TP AFTER 12 WEEKS OF TREATMENT WITH REBETRON® IN HIV-HCV CO-INFECTED PATIENTS.
J. F. Rodriguez, M. Melendez, R. Blanco, O. Rosario, W. Delgado, S. Davila, D. Casiano, H. Garcia, O. Mendez, S. Marrero, P. Costas, C. Gonzalez, C. Perez, J. R. Rodriguez, J. Santana
January 05, 52 (Suppl 2) S387; DOI: 10.1136/jim-52-suppl2-136